So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Eli Lilly & Co. tapped the US investment-grade bond market on Monday to help finance its roughly $2.5 billion purchase of a ...

Telehealth company Hims & Hers is pushing the boundaries of drug compounding and testing the limits of regulators.

The contest, held during the Super Bowl pregame show on Sunday, set the stage for FanDuel’s second-quarter ad, which celebrated Eli’s win and the fans who won bet credits for picking Eli to win on the ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...